Pivanex (AN-9), a derivative of Butyric acid, is an orally active HDAC inhibitor. Pivanex down-regulates bcr-abl protein and enhances apoptosis. Pivanex has antimetastic and antiangiogenic properties[1].
Molecular Weight:
202.25
Purity:
95
CAS Number:
[122110-53-6]
Formula:
C10H18O4
Target:
Apoptosis,Bcr-Abl,HDAC
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
